Similar to CERT, other LTPs that regulate phosphoinositides, shingolipids and cholesterol can affect different signaling and metabolic pathways to enhance cell survival, growth and motility or to inhibit cell death, and consequently could affect cancer progression, metastasis and/or response to treatment (Figure 4). The gene discussed is CERT1; the disease is cancer.